← Back to Screener
Alvotech Ordinary Shares (ALVO)
Price$3.62
Favorite Metrics
Price vs S&P 500 (26W)-61.82%
Price vs S&P 500 (4W)-9.51%
Market Capitalization$1.14B
P/E Ratio (Annual)40.91x
All Metrics
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)90.62%
Cash Flow / Share (Quarterly)$-0.47
Price vs S&P 500 (YTD)-31.30%
Gross Margin (TTM)60.00%
Net Profit Margin (TTM)4.74%
EPS (TTM)$0.05
10-Day Avg Trading Volume0.36M
EPS Excl Extra (TTM)$0.05
Revenue Growth (5Y)53.35%
EPS (Annual)$0.10
Gross Margin (Annual)60.00%
Net Profit Margin (5Y Avg)-298.62%
Cash / Share (Quarterly)$0.55
P/E Basic Excl Extra (TTM)40.91x
Revenue Growth QoQ (YoY)10.14%
P/E Normalized (Annual)40.91x
ROA (Last FY)1.88%
Revenue Growth TTM (YoY)19.70%
EBITD / Share (TTM)$0.48
Operating Margin (TTM)17.64%
Cash Flow / Share (Annual)$-0.47
Net Income / Employee (Annual)$0
EV / Revenue (TTM)4.11x
Net Interest Coverage (TTM)-0.02x
ROA (TTM)2.02%
EV / EBITDA (TTM)17.07x
EPS Incl Extra (Annual)$0.10
Current Ratio (Annual)1.89x
Quick Ratio (Quarterly)1.16x
3-Month Avg Trading Volume0.54M
52-Week Price Return-57.09%
P/E Incl Extra (TTM)40.91x
Revenue / Employee (TTM)$1
P/S Ratio (Annual)1.94x
Asset Turnover (Annual)0.40x
52-Week High$11.85
Operating Margin (5Y Avg)-207.16%
EPS Excl Extra (Annual)$0.10
CapEx CAGR (5Y)51.66%
26-Week Price Return-57.83%
Quick Ratio (Annual)1.16x
13-Week Price Return-25.76%
Current Ratio (Quarterly)1.89x
Enterprise Value$2,418.883
Revenue / Share Growth (5Y)-1.04%
Asset Turnover (TTM)0.43x
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.35x
Pretax Margin (Annual)23.15%
Cash / Share (Annual)$0.55
3-Month Return Std Dev57.50%
Net Income / Employee (TTM)$0
Net Interest Coverage (Annual)1.85x
EPS Basic Excl Extra (Annual)$0.10
Receivables Turnover (TTM)3.26x
EPS Incl Extra (TTM)$0.05
Receivables Turnover (Annual)3.26x
P/S Ratio (TTM)1.94x
Pretax Margin (5Y Avg)-348.62%
Revenue / Share (Annual)$2.11
Forward P/E114.33x
Price vs S&P 500 (52W)-86.92%
P/E Ratio (TTM)40.91x
Year-to-Date Return-28.66%
5-Day Price Return1.67%
EPS Normalized (Annual)$0.10
ROA (5Y Avg)-30.83%
Net Profit Margin (Annual)4.74%
Month-to-Date Return6.71%
EBITD / Share (Annual)$0.51
Operating Margin (Annual)17.64%
P/E Excl Extra (TTM)40.91x
EPS Basic Excl Extra (TTM)$0.05
Inventory Turnover (TTM)1.35x
Pretax Margin (TTM)23.15%
Price vs S&P 500 (13W)-26.45%
Beta0.28x
Revenue / Share (TTM)$2.11
52-Week Low$3.03
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.92
3.92
3.92
3.92
Industry Peers — Biological Products(88)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ALVOAlvotech Ordinary Shares | 1.94x | 19.70% | 60.00% | — | $3.62 |
AMGNAmgen Inc | 5.13x | 9.95% | 73.30% | 2.93% | $349.39 |
GILDGilead Sciences Inc | 5.84x | 2.40% | 78.83% | 133.64% | $138.55 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $828.35 |
BNTXBioNTech SE American Depositary Share | 8.75x | -11.81% | 84.21% | — | $102.12 |
BIIBBiogen Inc. Common Stock | 2.60x | 2.22% | 75.69% | -18.77% | $176.02 |
MRNAModerna, Inc. Common Stock | 11.02x | -39.93% | 70.32% | — | $54.68 |
NBIXNeurocrine Biosciences Inc | 4.49x | 21.45% | 98.18% | 2.31% | $128.41 |
EXELExelixis Inc | 4.96x | 6.85% | 96.39% | 31.10% | $44.38 |
TECHBio-Techne Corp. | 7.60x | 1.64% | 66.60% | -20.58% | $57.36 |
HALOHalozyme Therapeutics, Inc. | 5.74x | 37.55% | 83.62% | 22.89% | $66.64 |
About
Alvotech is an integrated biopharmaceutical company that develops and manufactures biosimilar medicines. The company creates affordable alternatives to existing biologic therapies, expanding patient access to treatments while leveraging its integrated research, development, and manufacturing capabilities.